Neurothekeomas are rare, benign soft tissue tumors with fairly distinctive histomorphological features. They arise from the nerve sheath (nerve sheath myxoma/myxoid type) or fibrohistiocytic matrix (cellular type) and commonly involve the face, neck, and upper extremities in young adults. We report a rare, mixed-type neurothekeoma (showing both myxoid and cellular features), affecting the jaw of an 11-year-old girl. Histology was consistent with typical myxoid pattern, while immunohistochemistry suggested a fibrohistiocytic origin (cellular pattern). We excised the mass completely without any evidence of recurrence after 6 months.
Introduction
Neurothekeomas are rare, benign soft tissue tumors commonly affecting the adolescents, usually affecting the head, neck, and upper extremities. [1] Histologic variants include myxoid, cellular, and myxoid-cellular (mixed) type. [1, 2] To the best of our knowledge, there are only five reports of mixed variety (myxoid-cellular) of this tumor in the English literature to date [ Table 1 ]. [3] [4] [5] [6] [7] Among them, only one case has been reported in the pediatric age group. [6] Thus, we report the rare myxoid-cellular/mixed variety of this uncommon tumor affecting the jaw of an 11-year-old female and discuss the histological and immunohistochemical findings along with the review of literature. year-old girl presented with an asymptomatic, progressively enlarging mass affecting the superolateral aspect of her jaw for the last 6 years. There was no history of constitutional symptoms or trauma. Physical examination revealed a palpable pinkish-purple, nontender nodule over her right jaw [ Figure 1 ]. The nodule was firm, mobile, nonfluctuant about 1 cm × 1 cm in dimension, without any overlying skin inflammation. Residual systemic examination was unremarkable.
Case Report
Routine biochemistry including full blood count and lactate dehydrogenase was within normal limits. We performed complete excision with biopsy and advised follow-up after 6 months. Histopathology demonstrated a well-circumscribed multilobulated dermal tumor separated by fibrous septae [Figure 2a ], exhibiting spindle-to-stellate-shaped cells with scanty fibrocollagenous tissue and moderate amount of fibrillary eosinophilic cytoplasm embedded in abundant myxoid stroma [ Figure 2b and c]. Resection margin was clear from tumor. Immunohistochemical staining was positive for cluster of differentiation (CD) 68 and negative for S100 and glial fibrillary acidic protein (GFAP) [ Figure 3a and b]. In addition, cytokeratin and smooth muscle actin staining were negative, excluding tumor of neural, epithelial, or muscle origin. Ki-67 proliferative index was <5%. Although histopathology showed typical features of myxoid variant, we confirmed the diagnosis of myxoid-cellular (mixed-type) neurothekeoma based on positive staining for fibrohistiocytic marker (CD68). No evidence of recurrence was noted 6 months postsurgery.
Discussion
Neurothekeomas are rare, benign soft tissue tumors with unknown histogenesis. [8] Although historically linked with nerve sheath myxoma and often considered synonymous, recent immunohistochemistry studies have separated these two and established fibrohistiocytic differentiation to be its hallmark characteristic. [2, 3, 9] Clinical features include a flesh-colored or slightly erythematous slow-growing papule or nodule of soft consistency. [9] Neurothekeomas have been subclassified histopathologically into three groups, depending on the amount of myxoid matrix-myxoid type (>50% myxoid matrix), mixed type (>10% but ≤50% myxoid matrix), and cellular type (≤10% myxoid matrix). [2] The typical histological features included a lobulated, well-circumscribed proliferation of stellate, spindled, or epithelioid cells arranged in the nests and cords with a mucinous, myxoid background containing dermal collagen bundles. [10] The myxoid variant shows greater degree of myxomatous changes (>50%), less cellularity with well-circumscribed spindle-to-stellate-shaped cells in myxoid matrix and multinucleated giant cells. [2, 11, 12] The tumor cells are positive for nerve-origin cell markers S100, GFAP, nerve growth factor receptor, collagen type IV, and CD57. [2, 8, 13] However, they are negative for epithelial membrane antigen or markers of histiocytic differentiation. [4, 5, 11] Interestingly, several authors have reported "S100-negative" myxoid neurothekeoma [4, 5] [ Table 1 ].
In contrast, the cellular types are nonencapsulated, poorly circumscribed, and typically composed of fascicles of spindle-shaped to epithelioid tumor cells with eosinophilic cytoplasm and sparse to absent mucinous matrix. [12, 14] The tumor cells are not stained with nerve-origin cell markers but show reactivity with fibrohistiocytic differentiation markers, NK1-C3 (CD63), CD10, and CD68, and the pan-monocyte marker, Ki-M1p. [11, 14, 15] The diagnosis of cellular neurothekeoma requires immunohistochemistry to identify the fibrohistiocytic markers in addition to histologic appearance. [16, 17] The mixed-type neurothekeoma usually shows overlapping features of both variants with interspersed cellular and myxoid regions. [12] Immunohistochemistry staining is often confusing, revealing irregular or absent reactivity to S100 protein, smooth muscle actin, and positive reaction for fibrohistiocytic differentiation markers. [12] Strumìa et al. and Henmi et al. reported two cases of S100-negative myxoid neurothekeoma despite distinct myxoid-type by histology. [4, 5] However, fibrohistiocytic marker such as CD68 was not performed in these two cases. [4, 5] Furthermore, another three case reports with contradictory morphological and immunohistochemical findings have been reported (typical myxoid-type histologic findings but negative for S100 protein and positive for fibrohistiocytic staining [CD68, NK1/C3, and Ki-M1P]), similar to our case [ Table 1 ]. [3, 6, 7] In our case, histopathology showed spindled-to-stellate cells embedded in abundant myxoid stroma (>50% myxoid matrix), consistent with myxoid variant [ Figure 2b and c]. However, immunohistochemical staining was suggestive of cellular variant (S100-negative; CD68-positive) [ Figure 3a and b]. Thus, a diagnosis of myxoid-cellular (mixed type) neurothekeoma was made. Complete excision was successful without any recurrence after 6 months. Complete excision is the treatment of choice, irrespective of its type. [18] There is no clear consensus on extent of resection margin, but clear microscopic margin is adequate. [18] Few studies have evaluated its prognosis to record a recurrence rate of around 3%, especially in the presence of risk factors such as myxoid type, female gender, facial location, younger age at diagnosis, positive margins, and absence of fat tissue in the sample. [2, 9, 18] 
Conclusion
Pediatric myxoid-cellular/mixed neurothekeoma is rare. Myxoid-type neurothekeoma demonstrates abundant myxoid matrix histologically, while fibrohistiocytic differentiation markers are necessary to diagnose the cellular variant. In the absence of S100 myxoid neurothekeoma, it is essential to perform immunohistochemical staining with fibrohistiocytic markers to differentiate mixed-type neurothekeoma for proper evaluation of recurrence risk.
This case has been highlighted to report a rare variant of an uncommon tumor in the pediatric age group.
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Age at presentation (year old)

Location Histology Immunochemistry Diagnosis
Strumìa et al. [4] 33 Trunk Lobular pattern with myxoid nodules clustered in a fibrous matrix in the reticular dermis
Alcian blue staining: Positive
Negative for S100
Fibrohistocytic markers not performed S100-myxoid neurothekeoma
Henmi et al. [5] 52 Nostril Numerous nests and cords of spindle-shaped cells in the dermis with myxomatous appearance and various amount of mucinous matrix in the intercellular space Negative for S100
Fibrohistocytic markers not performed S100-myxoid neurothekeoma Tas et al. [7] 69 Leg Single large nodule with scattered stellate and spindle-shaped cell on a myxoid-rich stroma Negative for S100, GFAP Positive for CD68, vimentin, and NKIC3 (CD57)
Myxoid cellular neurothekeoma
Sook JY et al. [3] 30 Eyebrow Stellate and spindle-shaped cells within an abundant myxoid stroma Negative for S100, GFAP, CD57
Positive for CD68, vimentin
Han TY et al. [6] 6 Forearm Epithelioid and spindle-shaped cells. Multinucleated giant cells and moderate to severe nuclear pleomorphism were seen Negative for S100 protein and GFAP Positive for NK1C3 and NSE
Vida et al.
11
Jaw Stellate and spindle-shaped cells with nuclear pleomorphism embedded within abundant myxoid stroma
CD68 positive
Myxoid cellular neurothekeoma GFAP -Glial fibrillary acidic protein; CD -Cluster of differentiation; NSE -Neuron-specific enolase
